Major adverse cardiovascular events in cancer patients during and after treatment with immune checkpoint inhibitors
01.11.2024
Klinische Forschung -
01.11.2024 - 31.10.2027
Geplant
Mitarbeiter/innen: Scheler Eva, Kuster Gabriela M, Zippelius Alfred, Rothschild Sacha I
Weiter
